Anti-EGFR domain III [h-R3 (Nimotuzumab)]
AB00723-2.0-BT
ApplicationsFlow Cytometry, ImmunoHistoChemistry, Neutralisation/Blocking
Product group Antibodies
ReactivityHuman
TargetEGFR
Overview
- SupplierAbsolute Antibody
- Product NameAnti-EGFR domain III [h-R3 (Nimotuzumab)]
- Delivery Days Customer9
- Application Supplier NoteThis antibody binds to human EGFR and inhibits EGF-dependent clonogenic growth of NRK cells and completely blocks EGF stimulated autophosphorylation of the receptor (Fernandez 1992)
- ApplicationsFlow Cytometry, ImmunoHistoChemistry, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDh-R3 (Nimotuzumab)
- Gene ID1956
- Target nameEGFR
- Target descriptionepidermal growth factor receptor
- Target synonymsERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS, PIG61, mENA, epidermal growth factor receptor, EGFR vIII, avian erythroblastic leukemia viral (v-erb-b) oncogene homolog, cell growth inhibiting protein 40, cell proliferation-inducing protein 61, epidermal growth factor receptor tyrosine kinase domain, erb-b2 receptor tyrosine kinase 1, proto-oncogene c-ErbB-1, receptor tyrosine-protein kinase erbB-1
- HostMouse
- IsotypeIgG2a
- Protein IDP00533
- Protein NameEpidermal growth factor receptor
- Scientific DescriptionThis chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.
- ReactivityHuman
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC41116161



